ISPOR Releases 2022 Annual Report

Published Apr 25, 2023

ANNOUNCEMENT

Return to In-Person Events Is Highlighted in New Report

LMIC Report CoverLawrenceville, NJ, USA—May 25, 2023—ISPOR—The Professional Society for Health Economics and Outcomes Research announced that its 2022 annual report has been published. This year’s report highlights how the Society has successfully moved through and beyond the pandemic and returned to in-person events as it advances its mission to improve healthcare decisions. During 2022 the Society:

  • Returned to in-person events with its 2 highly successful annual conferences—ISPOR 2022 and ISPOR Europe 2022
  • Organized and held a Asia Pacific Summit, Payer Summit, 5 Health Technology Assessment Roundtables, 3 Patient Engagement Roundtables, 51 short courses, and 39 webinars
  • Published 10 new ISPOR Reports in Value in Health, 4 of which were Good Practices Reports)
    • This included the update of the Society’s most downloaded report, “Consolidated Health Economic Evaluation Reporting Standards 2022,” also known as “CHEERS 2022”
  • Grew membership to 19,000 individual and chapter members representing 111 countries across the globe
  • Released a number of new content offerings, including the ISPOR 2022-2023 Top 10 HEOR Trends Report, About Real-World Evidence website content, and the HEOR News Desk microsite
  • Responded to 13 calls for comment that included responses to the US Food and Drug Administration (FDA), EUnetHTA, National Institute for Health and Care Excellence (NICE), and the European Medicines Agency (EMA)
  • Announced plans for ISPOR’s CEO and Executive Director for the past 8 years, Nancy S. Berg, to retire

The full report can be downloaded here.

###

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram 

Related Stories

Global Experts Highlight Concerns With Implementation of IRA-Mandated Medicare Drug Price Negotiation Program

Dec 5, 2023

Value in Health announced the publication of 2 new commentaries by leading experts in health economics and outcomes research, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.

Medicare Could Save an Additional $10 Billion Annually Across 10 Drugs by Using a Therapeutic Reference Pricing Approach in Upcoming Price Negotiations

Nov 7, 2023

Value in Health announced the publication of a study showing that United States Medicare could save up to an additional $5-$10 billion dollars annually across 10 drugs if it negotiated prices using a therapeutic reference pricing approach rather than using the statutory ceiling price alone.

Global Medical Device Panel Finds Little Evidence Linking Health Technology Assessment Processes to Medical Device Purchasing Decisions

Nov 6, 2023

Value in Health, the official journal of ISPOR, announced the publication of the results of a systematic literature review showing that there is sparce evidence in the health research literature to link health technology assessment processes and outcomes with device purchasing decisions
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×